Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Skinvisible (SKVI) Equity Ratio (2016 - 2025)

Skinvisible's Equity Ratio history spans 16 years, with the latest figure at 74.87 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 12.78% year-over-year to 74.87; the TTM value through Sep 2025 reached 74.87, down 12.78%, while the annual FY2024 figure was 58.3, 5.23% down from the prior year.
  • Equity Ratio for Q3 2025 was 74.87 at Skinvisible, down from 68.03 in the prior quarter.
  • Across five years, Equity Ratio topped out at 18.16 in Q2 2022 and bottomed at 74.87 in Q3 2025.
  • The 5-year median for Equity Ratio is 42.95 (2023), against an average of 43.85.
  • The largest annual shift saw Equity Ratio grew 17.91% in 2022 before it crashed 136.5% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 23.83 in 2021, then dropped by 12.93% to 26.91 in 2022, then crashed by 105.89% to 55.4 in 2023, then fell by 5.23% to 58.3 in 2024, then decreased by 28.43% to 74.87 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Equity Ratio are 74.87 (Q3 2025), 68.03 (Q2 2025), and 63.39 (Q1 2025).